Drug Shortage Report for TARO-TEMOZOLOMIDE

Last updated on 2017-10-02 History
Report ID 6914
Drug Identification Number 02443538
Brand name TARO-TEMOZOLOMIDE
Common or Proper name TEMOZOLOMIDE
Company Name TARO PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) TEMOZOLOMIDE
Strength(s) 140MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 5 blister
ATC code L01AX
ATC description ALKYLATINGAGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-04-25
Actual start date
Estimated end date 2017-10-09
Actual end date 2017-10-01
Shortage status Resolved
Updated date 2017-10-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2017-10-02 French Compare
v14 2017-10-02 English Compare
v13 2017-10-02 English Compare
v12 2017-09-08 French Compare
v11 2017-09-08 English Compare
v10 2017-08-02 French Compare
v9 2017-08-02 English Compare
v8 2017-06-20 French Compare
v7 2017-06-20 English Compare
v6 2017-05-30 French Compare
v5 2017-05-30 English Compare
v4 2017-04-26 English Compare
v3 2017-04-13 French Compare
v2 2017-04-13 English Compare
v1 2017-04-13 English Compare

Showing 1 to 15 of 15